Course Overview
Improving VTE Risk Assessment and Prophylaxis in Hospitalized Oncology Patients
Overview: This performance improvement implementation guide is one of several certified educational activities in the initiative, Performance Improvement Strategies in VTE Risk Assessment and Prophylaxis. This initiative offers a comprehensive series of activities designed to cover a broad range of topics on venous thromboembolism (VTE) prevention, with the ultimate goal of helping healthcare professionals improve the care of hospitalized patients at risk of VTE.
Faculty
Thomas L. Ortel, MD, PhD
Director, Anticoagulation Management Service
Director, Duke Clinical Coagulation and Platelet Immunology Laboratories
Professor of Medicine and Pathology
Division of Hematology
Duke University Health System
Durham, NC
Samuel Z. Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, VTE Research Group
Department of Medicine, Cardiovascular Division
Brigham and Women’s Hospital
Boston, MA
Alok A. Khorana, MD, FACP
Associate Professor of Medicine and Oncology
Vice-Chief, Division of Hematology/Oncology
James P. Wilmot Cancer Center
University of Rochester
Rochester, NY
Andrew F. Shorr, MD, MPH
Associate Director, Pulmonary and Critical Care Medicine
Chief, Pulmonary Clinic
Washington Hospital Center
Associate Professor of Medicine
Department of Pulmonary and Critical Care Medicine
Georgetown University
Washington, DC
Credits available: A maximum of 1.5 AMA PRA Category 1 Credits™
Types of credit available:
AMA PRA Category 1 Credit™
Expires: 5/18/11
This activity has been approved for AMA PRA Category 1 Credit™
Supported by an educational grant from:
Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.
Bookmark These Med-IQ Sites
Med-IQ Specialty Sites
